Back
Corporate News
At meeting held on 06 February 2026
Board of Tarsons Products approves investment of EUR 3 million in Tarsons Life Science
06-Feb-2026, 01:27
The board of Tarsons Products at its meeting held on 06 February 2026 has approved equity infusion of further EUR 3 Million in its wholly-owned subsidiary, Tarsons Life Science, a company incorporated in Singapore for meeting its operational and financial expenses.
The board of Tarsons Products at its meeting held on 06 February 2026 has approved equity infusion of further EUR 3 Million in its wholly-owned subsidiary, Tarsons Life Science, a company incorporated in Singapore for meeting its operational and financial expenses.
Powered by Capital Market - Live News